Patents by Inventor Peter Hindersson

Peter Hindersson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030082514
    Abstract: Biologically active peptides and nucleic acids are identified by a method comprising the following steps: (a) production of a pool of appropriate vectors each containing totally or partly random DNA sequences, (b) efficient transduction of said vectors into a number of identical eukaryotic cells in such a way that a single ribonucleic acid and possibly peptide is expressed or a limited number of different random ribonucleic acids and peptides are expressed by each cell, (c) screening of said transduced cells to see whether some of them have changed a certain phenotypic trait, (d) selection and cloning of said changed cells, (e) isolation and sequencing of the vector DNA in said phenotypically changed cells, and (f) deducing the ribonucleic acid and peptide sequences from the DNA sequence. The peptide sequences may be introduced into or fused to a larger protein, preferably an antibody molecule or a fragment thereof.
    Type: Application
    Filed: June 20, 2002
    Publication date: May 1, 2003
    Applicant: Pharmexa A/S
    Inventors: Martin Roland Jensen, Finn Skou Pedersen, Soren Mouritsen, Peter Hindersson, Mogens Duch, Michael Schandorf Sorensen, Iben Dalum, Anders Henrik Lund
  • Publication number: 20010053523
    Abstract: A library is composed of viral vectors in which each of the vectors (a) involves a peptide expression cassette containing a random nucleotide sequence, (b) transduces a eukaryotic cell to allow expression of the random nucleotide sequence, and (c) is produced by (i) conventional random oligonucleotide synthesis or (ii) random codon synthesis where codons encode an even distribution of random amino acids.
    Type: Application
    Filed: May 15, 2001
    Publication date: December 20, 2001
    Applicant: M&E Biotech A/S.
    Inventors: Martin Roland Jensen, Finn Skou Pedersen, Soren Mouritsen, Peter Hindersson, Mogens Duch, Michael Schandorf Sorensen, Iben Dalum, Anders Henrik Lund